Skip to main content
SpringerLink
Log in

LHRH analogues do not protect the germinal epithelium during chemotherapy

An experimental animal investigation

  • Original Articles
  • Published:
Urological Research Aims and scope Submit manuscript

Summary

The protective effect of Decapeptyl, a d-Trp6-LHRH analogue, on the germinal epithelium of rats during chemotherapy was examined in an experimental animal study. Four groups were formed consisting of 15 (groups A and B) and 20 (groups C and D) Sprague-Dawley rats, respectively. The animals were treated as follows: group A (control group) was given 0.9% NaCl i.m.; group B (LHRH group) d-Trp6-LHRH analogue (Decapeptyl); group C (LHRH + chemotherapy group) Decapeptyl +_cyclophosphamide; group D (chemotherapy group) cyclophosphamide. The gonads were removed before therapy was initiated and on days 13, 52, and 182 after treatment and examined histologically. In addition, follicle-stimulating hormone (FSH) levels in the serum, a sensitive indicator of tubular damage, were determined. The most damaging effects of chemotherapy on histology and hormone levels were observed in the animals in group C, which were additionally treated with LHRH analogues. Therefore, it is not possible to protect the germinal epithelium of the rat with LHRH analogues during chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chapman RM, Sutcliffe SB, Rees LH, Edwards CR, Malpas SJ (1979) Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet I:285

    Google Scholar 

  2. Delbrück H (1985) Zytostatisch bedingte Spätstörungen. Klinikarzt 14:1418

    Google Scholar 

  3. Dowling KJ, Lewis RW, Schally AV (1984) Suppression of spermatogenesis in the non-human primate using a potent LHRH agonist — possible clinical implications. American Urological Association Annual Meeting, May 6–10, New Orleans (Abstract 494)

  4. Fairley KF, Barrie JU, Johnson W (1972) Sterility and testicular atrophy related to cyclophosphamide therapy. Lancet I:568

    Google Scholar 

  5. Glode LM, Robinson J, Gould SF (1981) Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet I:1132

    Google Scholar 

  6. Hilscher W (1985) Umwelt und Fertilität. Z Hautkr 60:1040

    Google Scholar 

  7. Hilscher W, Reichelt P (1968) Untersuchungen am Samenepithel der Ratte nach Gaben von “Endoxan” und “Natulan”. Beitr Pathol Anat 137:452

    Google Scholar 

  8. Krause W (1988) Use of buserelin for the protection of spermatogenesis in cytotoxic treatment. In: Höffken K (ed) LH-RH-agonists in oncology. Springer, Berlin Heidelberg New York, p 105

    Google Scholar 

  9. Kreuser ED, Hetzel WD (1988) Reproductive and endocrine gonadal capacity with and without GnRH analogue application during chemotherapy in patients treated for testicular cancer. In: Höffken K (ed) LH-RH agonists in oncology. Springer, Berlin Heidelberg New York, p 111

    Google Scholar 

  10. Lewis RW, Dowling KJ, von Schally A (1985) d-Tryptophan-6-analog of luteinizing hormone-releasing hormone as a protective agent against testicular damage caused by cyclophosphamide in baboons. Proc Natl Acad Sci USA 82:2975

    Google Scholar 

  11. Nseyo UO, Englander LS, Huben RP (1984) Protection of germinal epithelium with LHRH analog. American Urological Association Annual Meeting, May 6–10, New Orleans (Abstract 240)

  12. Propping D (1987) Samenkonservierung als Fertilitätsprophylaxe bei Tumorkranken und erfolgreiche homologe Inseminationsbehandlung. In: Propping D (ed) Fertilitätserhaltung bei Tumorpatienten. Grossc, Berlin, p 33

    Google Scholar 

  13. Sandow J, Beier B (1982) LHRH-agonists: mechanism of action on target tissues. In: Schroder HF, Richards B (eds) Therapeutic principles in metastatic prostatic cancer. Liss, New York (EORT genitourinary group monograph 2, part A)

    Google Scholar 

  14. Schwaiger R, Stief C, Ziegler M (1986) Tierexperimentell Untersuchung zur Verbesserung der Ischämietoleranz des Hodens. Urologe [A] 25:174

    Google Scholar 

  15. Thachil JV, Jewett MAS, Rider WD (1981) The effects of cancer and cancer therapy on male fertility. J Urol 126:141

    Google Scholar 

  16. Wagner FOT (1986) Neue diagnostische und therapeutische Möglichkeiten bei Störungen der männlichen Pubertät und Fertilität. Int Welt 9:313

    Google Scholar 

  17. Weinbauer GF, Nieschlag E (1988) Reversibility of GnRH-agonist-induced inhibition of testicular function: comparison between rat, monkey and man. In: Höffken K (ed) LH-RH-agonists in oncology. Springer, Berlin Heidelberg New York, p 91

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Kiel, Kiel, FRG

    I. Papadopoulos

Authors
  1. I. Papadopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papadopoulos, I. LHRH analogues do not protect the germinal epithelium during chemotherapy. Urol. Res. 19, 31–34 (1991). https://doi.org/10.1007/BF00294018

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00294018

Key words

Search

Navigation